Michele Iuliani (M Iuliani)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Journal for immunotherapy of cancer

Oncogene

Cancers

Biomedicines

Università Campus Bio-Medico di Roma

Università Campus Bio-Medico di Roma (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università Campus Bio-Medico di Roma Apr 01 2014

Italy

PostDoc Position

Education History

Università Campus Bio-Medico di Roma Jan 01 2011 - Dec 31 2014

Italy

PHD

Università degli Studi di Roma La Sapienza Jan 01 2008 - Jul 22 2010

Italy

MSC

Publications

Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
F Pantano, Sonia Simonetti, Michele Iuliani, M J Guillen, C Cuevas, P Aviles, S Cavaliere, A Napolitano, A Cortellini, A Mazzocca, Lorenzo Nibid, G Sabarese, Giuseppe Perrone, M Gambarotti, A Righi, E Palmerini, S Stacchiotti, M Barisella, A Gronchi, S Valeri, M Sbaraglia, A P Dei Tos, G Tonini, B Vincenzi
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models. Oncogene (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Francesco Pantano, Francesca Zalfa, Michele Iuliani, Sonia Simonetti, Francesco Pantano, Andrea Napolitano, Simone Tiberi, Marco Russano, Fabrizio Citarella, Simone Foderaro, Elisabetta Vulpis, Alessandra Zingoni, Laura Masuelli, Roberto Bei, Giulia Ribelli, Marzia Del Re, Romano Danesi, Bruno Vincenzi, Giuseppe Perrone, Giuseppe Tonini, Daniele Santini
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients. Cancers 14 (10) (2022)
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Andrea Napolitano, Umile Giuseppe Longo, Bruno Vincenzi, Paolo Orsaria, Vincenzo Denaro, Giuseppe Tonini, Daniele Santini, Pantano Francesco
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment. International journal of molecular sciences 23 (5) (2022)
Sonia Simonetti, Michele Iuliani, Marco Stellato, Silvia Cavaliere, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma. Journal for immunotherapy of cancer 10 (9) (2022)
Michele Iuliani, Sonia Simonetti, Giulia Ribelli, Silvia Cavaliere, Bruno Vincenzi, Giuseppe Tonini, Francesco Pantano, Daniele Santini
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation. Biomedicines 10 (9) (2022)
Michele Iuliani, Sonia Simonetti, Francesco Pantano, Giulia Ribelli, Alberto Di Martino, Vincenzo Denaro, Bruno Vincenzi, Antonio Russo, Giuseppe Tonini, Daniele Santini
Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma. Biology 10 (8) (2021)
Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz-Knoll, Michele Iuliani, Giulia Ribelli, Edith Bonnelye, Harriett Wikman, Sandra Geraci, Florian Bonin, Sonia Simonetti, Bruno Vincenzi, Saw See Hong, Sofia Sousa, Klaus Pantel, Giuseppe Tonini, Daniele Santini, Philippe Clézardin
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene 40 (7) (2021)
Francesco Pantano, Elisabetta Rossi, Michele Iuliani, Antonella Facchinetti, Sonia Simonetti, Giulia Ribelli, Alice Zoccoli, Bruno Vincenzi, Giuseppe Tonini, Rita Zamarchi, Daniele Santini
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer. Scientific reports 10 (1) (2020)
Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, Angela Calabrese, Francesco Pantano, Michele Iuliani, Daniele Santini, Nicola Silvestris, Angelo Vacca
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview. Cancers 11 (9) (2019)

Michele Iuliani.css-eqlu8i{font-size:small;padding-left:4px;} (M Iuliani)

Publication Activity (10 Years)

Top Topics

Top Venues

Michele Iuliani (M Iuliani)